New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 6, 1995, Pages 1320-1323

  Schmatz, D M ^a   Powles, M A ^a   McFadden, D ^a   Nollstadt, K ^a   Bouffard, F A ^a   Dropinski, J F ^a   Liberator, P ^a   Andersen, J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIPROTOZOAL AGENT; CILOFUNGIN; DEXAMETHASONE; GLUCAN; L 688786; L 693989; L 705589; L 731373; L 733560; LIPOPEPTIDE; PNEUMOCANDIN; PNEUMOCANDIN B0; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DNA PROBE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; IMMUNE DEFICIENCY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TROPHOZOITE;

EID: 0029049503     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.39.6.1320     Document Type: Article

References (0)